FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.2  |  FHIR Version n/a  User: [n/a]

49616005: Monoclonal antibody (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
82640015 Monoclonal antibody en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
787314018 Monoclonal antibody (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779819014 Monoclonal protein en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3779820015 Monoclonal immunoglobulin en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core


157 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Monoclonal antibody Is a Non-organ specific antibody false Inferred relationship Some
Monoclonal antibody Is a Antibody true Inferred relationship Some
Monoclonal antibody Is a monoklonalt immunglobulin false Inferred relationship Some
Monoclonal antibody Is a A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them. true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Gemtuzumab ozogamicin Is a True Monoclonal antibody Inferred relationship Some
Product containing infliximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing monoclonal antibody (product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Monoclonal antibody Inferred relationship Some 1
Product containing abciximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing daclizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing basiliximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing etanercept (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
abciximab 2 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing trastuzumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Trastuzumab 150 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
monoklonalt antistof fra mus The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
muromonab-CD3 1 mg/ml injektionsvæske, opløsning, hætteglas a 5 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
murin-humant monoklonalt IgG-antistof The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Infliximab 100mg powder for infusion solution vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
etanercept 25 mg pulver og solvent til injektionsvæske, opløsning, hætteglas The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Abciximab 10mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Etanercept 25mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Trastuzumab 440 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Daclizumab 25mg/5 mL solution The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Basiliximab 20mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Infliximab 100mg/vial injection The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing ibritumomab tiuxetan (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Ibritumomab tiuxetan 3.2mg injection solution 2mL vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Palivizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Rituximab (substance) Is a True Monoclonal antibody Inferred relationship Some
Product containing alemtuzumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Alemtuzumab 30mg/3mL infusion concentrate The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Escherichia coli monoklonalt antistof The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Canine lymphoma monoclonal antibody The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing adalimumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Infliximab 100 mg powder for solution for injection vial The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Omalizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Efalizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Tositumomab (substance) Is a True Monoclonal antibody Inferred relationship Some
daclizumab 25 mg/5 ml koncentrat til infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
basiliximab 20 mg injektionsvæske (pulver til rekonstitution) + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
basiliximab 10 mg injektionsvæske (pulver til rekonstitution) + solvens The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
adalimumab 40 mg injektionsvæske, opløsning i fyldt injektionssprøjte a 0,8 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
alemtuzumab 30 mg/3 ml koncentrat til infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Infliximab (substance) Is a True Monoclonal antibody Inferred relationship Some
Adalimunab 40mg/mL injection solution 1mL prefilled syringe The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing cetuximab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
cetuximab 2 mg/ml injektionsvæske, opløsning, hætteglas a 50 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing bevacizumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 4 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
bevacizumab 25 mg/ml injektionsvæske, opløsning, hætteglas a 16 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Ibritumomab tiuxetan The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
ibritumomab tiuxetan 1,6 mg/ml radiofarmaceutisk infusionssæt The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing muromonab-CD3 (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Natalizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Etanercept 25mg/vial powder The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
alemtuzumab 30 mg/ml koncentrat til infusionsvæske The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
monoklonalt antistof-agens Is a False Monoclonal antibody Inferred relationship Some
Iodine (124-I) labeled monoclonal antibody (substance) Is a False Monoclonal antibody Inferred relationship Some
Panitumumab (substance) Is a True Monoclonal antibody Inferred relationship Some
murin-humant monoklonalt IgG-antistof The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
monoklonalt antistof fra mus The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Product containing ustekinumab (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Monoclonal antibody Inferred relationship Some
Belimumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Besilesomab (substance) Is a True Monoclonal antibody Inferred relationship Some
Brentuximab vedotin (substance) Is a True Monoclonal antibody Inferred relationship Some
Alirocumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Idarucizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Necitumumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Daratumumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Blinatumomab (substance) Is a False Monoclonal antibody Inferred relationship Some
Olaratumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Bezlotoxumab (substance) Is a False Monoclonal antibody Inferred relationship Some
Dinutuximab (substance) Is a True Monoclonal antibody Inferred relationship Some
Ixekizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Obiltoxaximab (substance) Is a True Monoclonal antibody Inferred relationship Some
Raxibacumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Brodalumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Avelumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Ocrelizumab Is a True Monoclonal antibody Inferred relationship Some
Dupilumab Is a True Monoclonal antibody Inferred relationship Some
Muromonab-CD3 Is a True Monoclonal antibody Inferred relationship Some
murin-humant monoklonalt IgG-antistof Is a False Monoclonal antibody Inferred relationship Some
Ibritumomab tiuxetan (substance) Is a True Monoclonal antibody Inferred relationship Some
Adalimumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Bevacizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Ranibizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Eculizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Zanolimumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Oregovomab (substance) Is a True Monoclonal antibody Inferred relationship Some
Certolizumab pegol (substance) Is a True Monoclonal antibody Inferred relationship Some
Naptumomab (substance) Is a True Monoclonal antibody Inferred relationship Some
Golimumab Is a True Monoclonal antibody Inferred relationship Some
Ustekinumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Tocilizumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Denosumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Canakinumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Nivolumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Pertuzumab Is a True Monoclonal antibody Inferred relationship Some
Vedolizumab Is a True Monoclonal antibody Inferred relationship Some
Ramucirumab Is a True Monoclonal antibody Inferred relationship Some
Siltuximab Is a True Monoclonal antibody Inferred relationship Some
Secukinumab Is a True Monoclonal antibody Inferred relationship Some
Obinutuzumab (substance) Is a True Monoclonal antibody Inferred relationship Some
Catumaxomab Is a False Monoclonal antibody Inferred relationship Some
Elotuzumab (substance) Is a True Monoclonal antibody Inferred relationship Some

Page 1 of 2 End


This concept is not in any reference sets

Back to Start